An International Scientific Symposium for interaction and exchange among basic scientists and clinicians in breast cancer
San Antonio Breast Cancer Symposium (SABCS) 2023
This international scientific symposium allows for the important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. SABCS are committed to meet the needs of breast cancer patients through high-quality and equal access to care to include prevention, early detection, and treatment. The Mays Cancer Center agrees with the AACR’s position strongly affirming its support for equitable access to quality health care services for all patients. SABCS remains a champion of evidence-based health care, diversity, equity, inclusion and acceptance as core values which are deeply ingrained in their life’s work and mission.
This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers.
The scientific program consists of formal lectures by experts in clinical, translational, and basic research, selected slide and poster presentations, forums and case discussions. The official language of the symposium is English. Simultaneous translation is not provided.
This international symposium is directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as patient advocates and other appropriate health care professionals. They anticipate 9,500 attendees from more than 100 countries.
More content available within our dedicated Learning Zones and Speciality hubs
A detailed look at conditions connected to Oncology.
CDK4/6 inhibitors in breast cancer
Are you familiar with the clinical trial evidence that could help you to select the best cyclin dependent kinase 4/6 (CDK4/6) inhibitor for your metastatic breast cancer patient?
Prostate cancer mCRPC
Unmet needs in the management of mCRPC, with a focus on treatments.
Supportive care in oncology Learning Zone
Supportive care in oncology from a multidisciplinary team involves caring for patients with cancer, treatment adherence and adverse effect management.
Molecular diagnostics for RET inhibition in NSCLC and thyroid cancers
Discover assorted resources and expert opinions on molecular diagnostics for RET inhibition in non-small cell lung cancer (NSCLC) and thyroid cancers.